Information for you
On this page, you will find information on the Agency’s activities that are most relevant to healthcare professionals, including news, and events.
You can contribute to the Agency’s work by responding to public consultations.
Learn more about how Healthcare Professionals are actively involved in the work of the Agency.
Workshop on social media
EMA’s Patients’ and Consumers’ Organisations Working Party (PCWP) and Healthcare Professionals’ Organisations Working Party (HCPWP) discussed challenges and practical applications of social media and their impact on regulators, patients and healthcare professionals during a workshop held on 19 September 2016. A report of the workshop is expected to be published by EMA together with presentations.
It was the first in a series of meetings relating to advances in digital health, including social media, ‘big data’ analysis and Innovative Medicines Initiative (IMI) projects such as WEB-RADR, where EMA will provide a platform for discussion and mutual learning.
Tenth stakeholder forum on pharmacovigilance legislation
This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years. All the presentations have been published.
Healthcare professionals’ working party elects co-chair
EMA Healthcare Professionals' Working Party (HCPWP) has re-elected Gonzalo Calvo as its co-chair at the September 2016 meeting. Professor Calvo, a physician by education and consultant in clinical pharmacology in Barcelona, Spain, has extensive experience in medicines regulation, including nearly ten years as a member of EMA’s Committee for Medicinal Products for Human Use (CHMP).
Annual report on EMA patient and healthcare professional interactions
EMA has published its 2015 annual report on its interactions with patients, consumers, healthcare professionals and their organisations.The report demonstrates the Agency’s continued commitment to incorporating these stakeholders' views into the regulatory aspect of medicines development.
News for healthcare professionals
Workshop to be broadcast live on 28 October ... Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2016
Eight medicines recommended for approval, including four orphan medicines ... Read more
Recommendations for patients with kidney impairment updated in product information ... Read more
- See all News for healthcare professionals
Events of interest
12/09/2016 - 13/09/2016
This workshop is co-sponsored by the EMA and the Critical Path Institute. It focuses on reviewing the progress and exploring new initiatives for the International Neonatal Consortium (INC), which is dedicated to accelerating the development of safe and effective therapies for neonates. One cross-cutting topic is how to enhance a research culture. Other overarching topics are precision medicine for neonates and long-term outcome measures. Therapeutic areas that will be examined include Neonatal Abstinence Syndrome (NAS) and Necrotizing Enterocolitis (NEC). ... Read more
This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years. ... Read more
EMA workshop on qualification and reporting of physiologically-based pharmacokinetic (PBPK) modelling and simulation
EMA workshop is aimed at providing an opportunity to discuss the input received during the consultation, to disseminate its key messages and to provide details on qualification procedures and evaluation of drug models. It is also aimed at communicating EMA’s current thinking on the utility of PBPK with stakeholders from other regulatory agencies, pharmaceutical industry, academia, patient representatives and software developers. ... Read more
The European Medicines Agency is organising this workshop in collaboration with the European Commission to gather the views and proposals from stakeholders on the adaptive pathways approach, in light of the practical experience gained during the pilot project EMA ran between March 2014 and August 2016, and to plan the next steps in the exploration of this concept. Adaptive pathways is a scientific concept of medicines development and data generation intended for medicines that address patients’ unmet medical needs. ... Read more
This information day will review signal detection and management activities essential to the overall risk management process of a medicinal product. The event will explain the impact of the implementation of the 2010 pharmacovigilance legislation, with a strong focus on signal detection and management within the European Union, emphasising the requirements to be implemented in 2017. ... Read more
- See all Events of interest